MedTrace Logo

A Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica

NCT01684358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 414

Last updated 2014-11-05

No results posted yet for this study

Summary

This unblinded, randomized controlled trial (RCT) among women to determine:

1)if unprotected sex as measured prostate-specific antigen (PSA) will be more among women who receive a contraceptive implant immediately at baseline during three months of follow up compared to women who receive the implant at the three month follow-up visit.

Conditions

  • Women Wanting Contraceptive Implant for Pregnancy Prevention

Interventions

DEVICE

Sino-implant (II)

Sino-implant (II) (Shanghai Dahua Pharmaceutical Co, Ltd.; Shanghai, China), a contraceptive implant with two rods each of which contain 75 mg of levonorgestrel.

Sponsors & Collaborators

Principal Investigators

  • Carole Rattray, DM · University of West Indies

  • Elizabeth Costenbader, PhD · FHI 360

  • Athena Kourtis, MD, PhD, MPH · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Jamaica

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684358 on ClinicalTrials.gov